Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) CAO Michael P. Dube sold 2,012 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $19.01, for a total value of $38,248.12. Following the sale, the chief accounting officer now directly owns 47,012 shares […]

Sezzle Inc. (NASDAQ:SEZL – Get Free Report) Director Paul Martin Purcell sold 7,824 shares of the company’s stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $164.86, for a total value of $1,289,864.64. Following the completion of the transaction, the director now directly owns 82,776 shares in […]

ACM Research, Inc. (NASDAQ:ACMR – Get Free Report) Director Xiao Xing sold 8,304 shares of ACM Research stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $20.19, for a total transaction of $167,657.76. Following the completion of the sale, the director now owns 3,430,206 shares in the […]

Zuora, Inc. (NYSE:ZUO – Get Free Report) insider Andrew M. Cohen sold 20,773 shares of the company’s stock in a transaction dated Thursday, October 3rd. The stock was sold at an average price of $8.34, for a total transaction of $173,246.82. Following the completion of the transaction, the insider now owns 172,033 shares of the […]

Sezzle Inc. (NASDAQ:SEZL – Get Free Report) Director Paul Martin Purcell sold 7,824 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $164.86, for a total value of $1,289,864.64. Following the completion of the transaction, the director now directly owns 82,776 shares in […]

Vericel Co. (NASDAQ:VCEL – Get Free Report) Director Steven C. Gilman sold 5,833 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $40.35, for a total transaction of $235,361.55. Following the transaction, the director now directly owns 11,000 shares of the company’s stock, valued […]